- ICH GCP
- US Clinical Trials Registry
- Klinisk utprøving NCT00710645
Lido Workset Study
Assessment of Spasticity in MS Patients Using a Lido Workset
Studieoversikt
Detaljert beskrivelse
The information gathered from testing individuals with spasticity due to multiple sclerosis with the Lido Workset has been important in making adjustments to the Lido Workset to show a greater degree of sensitivity in assessing varying degrees of spasticity.
Healthy control subjects will be used to compare the spasticity data of multiple sclerosis subjects with subjects with normal muscle tone to determine the sensitivity of the Lido measurements.
The testing will be performed one time for each patient and will take approximately 25 minutes. The servo-controlled torque motor system will analyze resistance to passive movement of the knee. This testing may be repeated for a group of randomly selected subjects from both the MS subjects and control subjects. The testing for this subset of subjects will be done as follows: first session, second session one week after the first session, third session three weeks after the first session. The total length of time for participation in this study may be up to three weeks. This additional testing will be done in order to compare the results with the Lido data obtained at similar timepoints from the subjects enrolled in the Cannabis for Spasticity in MS study. Each subject will be given the option to participate in the extended testing or to decline.
Studietype
Registrering (Faktiske)
Kontakter og plasseringer
Studiesteder
-
-
California
-
Sacramento, California, Forente stater, 95817
- University of California, Davis
-
-
Deltakelseskriterier
Kvalifikasjonskriterier
Alder som er kvalifisert for studier
Tar imot friske frivillige
Kjønn som er kvalifisert for studier
Prøvetakingsmetode
Studiepopulasjon
Beskrivelse
Inclusion Criteria:
- Must have a diagnosis of multiple sclerosis and
- Must have some degree of spasticity or
- Must be a healthy control subject
- Ability to give informed consent
Exclusion Criteria:
- Patients with any life-threatening or unstable clinically significant disease
- Patients with other causes of reduced range of motion of the knee or wrist
Studieplan
Hvordan er studiet utformet?
Designdetaljer
Kohorter og intervensjoner
Gruppe / Kohort |
Intervensjon / Behandling |
---|---|
Arm I
50 subjects with multiple sclerosis will be tested one time on the Lido Workset.
The test will take approximately 25 minutes.
The servo-controlled torque motor system will analyze resistance to passive movement of the knee.
This testing may be repeated for a group of randomly selected subjects.
Each subject will be given the option to participate in the extended testing or to decline.
The testing for this subset of subjects will be done as follows: first session, second session one week after the first session, third session three weeks after the first session.
The total length of time for participation in this study may be up to three weeks.
|
The intervention will consist of spasticity testing on the Lido Workset device.
The servo-controlled torque motor system will analyze resistance to passive movement of the knee.
|
Arm II
25 normal subjects will be tested on the Lido workset.
The testing will be performed one time for each patient and will take approximately 25 minutes.
The servo-controlled torque motor system will analyze resistance to passive movement of the knee.
This testing may be repeated for a group of randomly selected control subjects.
Each subject will be given the option to participate in the extended testing or to decline.
The testing for this subset of subjects will be done as follows: first session, second session one week after the first session, third session three weeks after the first session.
The total length of time for participation in this study may be up to three weeks.
|
The intervention will consist of spasticity testing on the Lido Workset device.
The servo-controlled torque motor system will analyze resistance to passive movement of the knee.
|
Hva måler studien?
Primære resultatmål
Resultatmål |
Tidsramme |
---|---|
Assess measure of spasticity
Tidsramme: 3 weeks
|
3 weeks
|
Samarbeidspartnere og etterforskere
Sponsor
Etterforskere
- Hovedetterforsker: Mark Agius, MD, University of California, Davis
Studierekorddatoer
Studer hoveddatoer
Studiestart
Primær fullføring (Faktiske)
Studiet fullført (Faktiske)
Datoer for studieregistrering
Først innsendt
Først innsendt som oppfylte QC-kriteriene
Først lagt ut (Anslag)
Oppdateringer av studieposter
Sist oppdatering lagt ut (Faktiske)
Siste oppdatering sendt inn som oppfylte QC-kriteriene
Sist bekreftet
Mer informasjon
Begreper knyttet til denne studien
Nøkkelord
Ytterligere relevante MeSH-vilkår
Andre studie-ID-numre
- 200310977
Plan for individuelle deltakerdata (IPD)
Planlegger du å dele individuelle deltakerdata (IPD)?
Denne informasjonen ble hentet direkte fra nettstedet clinicaltrials.gov uten noen endringer. Hvis du har noen forespørsler om å endre, fjerne eller oppdatere studiedetaljene dine, vennligst kontakt register@clinicaltrials.gov. Så snart en endring er implementert på clinicaltrials.gov, vil denne også bli oppdatert automatisk på nettstedet vårt. .
Kliniske studier på Multippel sklerose
-
BiogenGodkjent for markedsføringSuperoxide Dismutase 1-Amyotropic Lateral SclerosisForente stater
Kliniske studier på Lido Workset
-
Virginia Polytechnic Institute and State UniversityCarilion Clinic; Thomas Jefferson University; Drexel University; Mazzoni Health... og andre samarbeidspartnereAktiv, ikke rekrutterendeSelvmord | Engasjement, pasientForente stater
-
Agency for Healthcare Research and Quality (AHRQ)Massachusetts eHealth CollaborativeFullført
-
Midwest Evaluation & ResearchGoodwill of Central TexasRekruttering
-
University Tunis El ManarAktiv, ikke rekrutterende
-
Merz North America, Inc.Fullført
-
Samsung Medical CenterRekrutteringDelirium, postoperativtKorea, Republikken